December 25, 2024 07:16 am (IST)
Glenmark launches Tavulus for COPD treatment in Spain
Oct 11, 2021, at 07:18 pm
Mumbai/UNI: Pharma major Glenmark Pharma Monday announced the launch of a bioequivalent version of Tiotropium Bromide dry powder inhaler (DPI) under the brand name Tavulus in Spain for the treatment of chronic obstructive pulmonary disease (COPD).
Latest Headlines
Glenmark launches Tavulus for COPD treatment in Spain
Mon, Oct 11 2021